$0.80 +0.03 (4.39%) Ampio Pharmaceuticals Inc - NYSE Amex Equities

Dec. 5, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 0.80
Trade Time: Dec 05 04:00 PM Eastern Daylight Time
Change: +0.03 (4.39%)
Prev Close: 0.77
Open: 0.80
Bid: 0.76
Ask: 0.84
  1. No results found.
  1. Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA Approval of Optina™, an Oral Treatment for Diabetic Macular Edema (DME)

    Benzinga | Oct. 14, 2015 | 08:02AM EST
  2. Morning Market Gainers

    Benzinga | Sep. 22, 2015 | 08:57AM EST
  3. AMPIO Receives Special Protocol Assessment from FDA; Commences Second Phase III pivotal trial of Ampion

    Benzinga | Sep. 22, 2015 | 07:04AM EST
  4. Morning Market Gainers

    Benzinga | May. 21, 2015 | 08:49AM EST
  5. Morning Market Losers

    Benzinga | Apr. 20, 2015 | 08:51AM EST
  6. Ampio Offers Update on Phase III Multicenter, Double-Blind STEP Study of Ampion

    Benzinga | Sep. 2, 2014 | 06:57AM EST
  7. Ampio Pharma Announces Responses to Questions Related to STEP Study

    Benzinga | Aug. 25, 2014 | 07:03AM EST
  8. Morning Market Losers

    Benzinga | Aug. 22, 2014 | 08:58AM EST
  9. Benzinga's Top Downgrades

    Benzinga | Aug. 22, 2014 | 08:44AM EST
  10. Jefferies Downgrades Ampio Pharmaceuticals To Hold

    Benzinga | Aug. 22, 2014 | 07:33AM EST
  11. Morning Market Losers

    Benzinga | Aug. 21, 2014 | 09:02AM EST
  12. Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane in Canada

    Benzinga | Apr. 10, 2014 | 07:05AM EST
  13. Ampio Pharma to Present Results of 20 Weeks Extension of Ampion SPRING Study at Western Orthopedic Association

    Benzinga | Apr. 9, 2014 | 07:11AM EST
  14. Ampio Pharmaceuticals Spins-Off Sexual Dysfunction Business

    Benzinga | Dec. 13, 2013 | 13:01PM EST
  15. Ampio Pharma Announces Results from Panel Review of the Interim Analysis of the Optina(TM) Trial, FDA Agrees to 505(B) 2 Pathway

    Benzinga | Oct. 7, 2013 | 07:06AM EST
Trading Center